This medicine is a long-acting injectable medication containing exenatide, used primarily for the management of type 2 diabetes.
It comes in a pre-filled pen format, with each pen delivering a dose of 2 mg of exenatide in a suspension for injection.
The medication works by mimicking the action of incretin hormones, which help regulate blood sugar levels.
Benefits:
-Helps lower blood sugar levels in adults with type 2 diabetes when used alongside diet and exercise.
-Can lead to weight loss in some patients, which is beneficial as obesity is often associated with type 2 diabetes.
-Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
Precautions:
-Not recommended for use in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
-Caution should be exercised in patients with a history of pancreatitis; it may increase the risk of this condition.
-Patients should be monitored for signs of hypoglycemia, especially if used with other antidiabetic medications.
Side Effects:
-Common side effects include nausea, vomiting, diarrhea, and abdominal pain.
-Serious side effects may include pancreatitis, kidney problems, allergic reactions (such as rash or difficulty breathing), and increased heart rate.
-Patients should report any severe gastrointestinal symptoms or signs of an allergic reaction to their healthcare provider immediately.
Main Ingredients and Their Benefts:
Exenatide is a GLP-1 receptor agonist that helps to lower blood sugar levels by enhancing insulin secretion in response to meals, thereby improving glycemic control in adults with type 2 diabetes.
Administer the medicine once weekly at any time of day, with or without meals.
Rotate injection sites between the abdomen, thigh, and upper arm to reduce irritation at the site.
Follow proper injection techniques as instructed by a healthcare professional to ensure correct dosing and minimize discomfort.
Exenatide, Polylactide-Co-Glycolide, Sucrose and Medium Chain Triglycerides